Zomedica Corp.
ZOMDF
$0.08
$0.00-2.67%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.88M | 34.33M | 32.03M | 29.45M | 28.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.88M | 34.33M | 32.03M | 29.45M | 28.36M |
| Cost of Revenue | 12.75M | 11.57M | 10.35M | 9.40M | 8.68M |
| Gross Profit | 24.13M | 22.76M | 21.68M | 20.06M | 19.68M |
| SG&A Expenses | 39.23M | 40.99M | 43.03M | 43.90M | 44.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.63M | 59.03M | 60.55M | 60.97M | 60.71M |
| Operating Income | -20.75M | -24.71M | -28.52M | -31.52M | -32.35M |
| Income Before Tax | -19.12M | -22.77M | -82.14M | -84.81M | -85.39M |
| Income Tax Expenses | -168.00K | -182.00K | -278.00K | -285.00K | -293.00K |
| Earnings from Continuing Operations | -18.95 | -22.58 | -81.86 | -84.52 | -85.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.95M | -22.58M | -81.86M | -84.52M | -85.10M |
| EBIT | -20.75M | -24.71M | -28.52M | -31.52M | -32.35M |
| EBITDA | -13.20M | -17.08M | -20.57M | -23.43M | -24.14M |
| EPS Basic | -0.02 | -0.02 | -0.08 | -0.09 | -0.09 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.08 | -0.09 | -0.09 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Average Diluted Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |